Vontobel Holding’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,716
Closed -$58.3K 1381
2025
Q2
$58.3K Buy
+11,716
New +$50.9K ﹤0.01% 1227
2024
Q4
Sell
-93,750
Closed -$651K 1127
2024
Q3
$651K Buy
93,750
+41,196
+78% +$323K ﹤0.01% 711
2024
Q2
$410K Sell
52,554
-8,751
-14% -$64.8K ﹤0.01% 828
2024
Q1
$435K Buy
+61,305
New +$406K ﹤0.01% 823
2022
Q4
Sell
-85,675
Closed -$412K 1100
2022
Q3
$412K Sell
85,675
-4,440
-5% -$28K ﹤0.01% 772
2022
Q2
$568K Buy
90,115
+20,234
+29% +$225K 0.01% 682
2022
Q1
$1.32M Sell
69,881
-25,450
-27% -$584K 0.01% 542
2021
Q4
$3.16M Buy
95,331
+2,670
+3% +$107K 0.03% 354
2021
Q3
$3.8M Sell
92,661
-28,045
-23% -$1.02M 0.03% 320
2021
Q2
$4.35M Buy
120,706
+9,357
+8% +$345K 0.04% 297
2021
Q1
$4.34M Buy
111,349
+40,381
+57% +$1.82M 0.03% 280
2020
Q4
$3.94M Buy
+70,968
New +$3.26M 0.03% 301

Other funds holding GDRX

Vontobel Holding's GDRX Position: Q3 2025 in Review

Vontobel Holding sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 11,716 shares — an estimated $58.3K sold.

Vontobel Holding first reported a position in GDRX in Q4 2020 and held it in 12 quarters. The position peaked at $4.35M in Q2 2021. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Vontobel Holding reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Vontobel Holding sold 11,716 GoodRx Holdings shares in Q3 2025, an estimated $58.3K.
  • Vontobel Holding first reported a position in GoodRx Holdings in Q4 2020 and held it in 12 quarters.
  • Vontobel Holding's GoodRx Holdings position peaked at $4.35M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Vontobel Holding's 13F filing for Q3 2025, filed 15 Oct 2025.